Meridian Health Ventures I

The challenge

A lack of investment in innovation, combined with fragmented health systems, is limiting the NHS’s capacity to meet growing demand. This has made it harder to embed and scale new technologies, as mechanisms to support adoption across the system remain limited. With health outcomes deteriorating and access to care becoming increasingly unequal, there is a pressing need to more effectively adopt validated innovations into the health system.

Our approach

We aim to build an ecosystem that consistently nurtures and scales new ways of tackling social problems – driving transformation in sectors where innovation is urgently needed, such as health. By partnering with specialist funds like MHV, we can support them to leverage deep sector expertise and user voice to drive positive impact on people and back ventures that prioritise impact as a driver of business value. MHV is strongly aligned with our health mission and employs a framework that aims to improve population health, enhance care experiences, reduce the cost of care, support the health and wellbeing of care providers, and advance health equity.

The Fund

Meridian Health Ventures I’s investors include three of the largest NHS Trusts in Guy’s & St Thomas’, King’s College Hospital and University College London Healthcare NHS Trusts. The Fund invests in digital health, enterprise healthcare, and MedTech companies providing solutions where there is a compelling case that the company can scale within the NHS. The Fund aims to provide practical, hands-on support for the ventures it invests in. This includes connectivity to key stakeholders in the NHS, guidance on building robust evidence for innovations and connectivity to health systems in the UK and U.S.

  • Fund size

    £31 million
  • Better Society Capital commitment

    £4 million

Key information

  • Geography

    UK wide
  • Investment type

    Enterprise equity
  • Investment status

    Current
  • Investment date

    May 2025
  • Term

    10 years